DAXOR CORP
Develops an FDA-cleared Blood Volume Analysis system for precise fluid management in hospitals.
DXR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US2394671034
- LEI:
- Country:
- United States of America
- Address:
- 350 FIFTH AVENUE, 10118 NEW YORK
- Website:
- https://www.daxor.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Daxor Corporation is a medical instrumentation and biotechnology company specializing in blood volume measurement technology. The company develops, manufactures, and markets the patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic system. This technology provides clinicians in hospital and ambulatory settings with precise, real-time data to guide fluid management for patients with conditions like heart failure, sepsis, and critical care needs. Building on over 50 years of innovation, Daxor's BVA system is designed to improve patient outcomes, reduce readmissions, and lower healthcare costs by enabling data-driven, individualized treatment decisions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all DAXOR CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DAXOR CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAXOR CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
